Validating a risk-prediction tool for lung infections
Part of Infections, Lungs & breathing clinical trials.
This study checks whether a new tool can predict how well patients with pneumonia (a lung infection) or sepsis (a severe body-wide infection) will do. It helps doctors plan the best care based on individual risk.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have been diagnosed with community-acquired pneumonia (a lung infection you got outside the hospital) or sepsis (a severe infection that can cause organ failure).
- Your symptoms started no more than 8 days before joining the study.
- You are able and willing to sign a consent form and follow the study schedule.
- You do not have severe heart, lung, liver, or kidney disease that could interfere with the study.
- You are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is building a tool to predict sepsis, a life-threatening response to infection, in intensive care patients. It may help doctors act faster to prevent complications.
This study looks at patients with sepsis (a severe infection that affects organs) and acute respiratory distress syndrome (ARDS, a serious lung condition) to learn more about these illnesses and improve care.
This trial studies people with and without sepsis in the ICU to understand why some get very sick from infections. It aims to find better ways to predict who will have complications and guide treatment.
This study follows how community-acquired pneumonia progresses in hospitalized patients who already have serious health problems or weakened immune systems. The goal is to better understand risk and changes over time, which may help guide future care for people like you.
This study looks at certain markers in the blood to help predict and understand lung injury in people who have sepsis from an infection outside the lungs. By joining, you help doctors learn how to better protect the lungs of future patients with sepsis.
This trial tests an emergency breathing-related approach for adults with a sudden, community-acquired respiratory infection. It may help doctors quickly sort out what’s going on and guide early care.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.